Wetenschappelijk onderzoek

Wetenschappelijke publicaties

PARC_Logo_cut.png

Hier zie je een overzicht van alle publicaties van het PARC van 2015 tot nu. Er is een apart overzicht van rapportages en (hoofdstukken in) boeken.

Wil je meer informatie over een publicatie?
Contact opnemen met PARC.

Publicaties:

2021

Bekijk het jaarverslag en de factsheet van 2021. 

  • Van Benthem P, Spijkerman R, Blanken P, Boon A, Vermeiren RRJM, Hendriks VM (2021). Systematic client feedback and adolescents' treatment outcomes in youth mental health and addiction care: A controlled study comparing two treatment cohorts. (submitted for publication).
  • Van Benthem P, Spijkerman R, Blanken P, Kleinjan M, Vermeiren RRJM, Hendriks VM (2021). Therapeutische alliantie als voorspeller van behandeluitkomst: de meerwaarde van jongeren en therapeuten perspectief. Tijdschrift voor Psychiatrie, 63 (7): 535-542. 
  • van Dorp M, Boon A, Spijkerman R, & Los L (2021). Substance use prevalence rates among migrant and native adolescents in Europe: A systematic review. Drug and Alcohol Review 40 (2), 325-339. doi: https://doi.org/10.1111/dar.13154
  • Hendriks VM,  Dom G (2021). Proactieve psychiatrie bij verslaving. Tijdschrift voor Psychiatrie, 63, 125-128.
  • Laaper E, van Benthem P, Nijland L (2021) Visie van ouders op therapeutische alliantie in jeugdbehandelingen: over samenhang en behandeluitkomst. Tijdschrift voor Psychotherapie  
  • Moazen-Zadeh E, Ziafat K, Yazdani K, Mamdouh M, Wong J, Modabbernia A, Blanken P, Verthein U, Schutz C, Jang K, Akhondzadeh S & Krausz M. (2021). Impact of opioid agonists on mental health in substitution treatment for opioid use disorder: A systematic review and Bayesian network meta-analysis of randomized clinical trials. American Journal of Drug and Alcohol Abuse, 47 (3): 280-304. doi: https://doi.org/10.1101/2020.07.04.20146506
  • Moska C, Goudriaan A, Blanken P, van de Mheen D, Spijkerman R, Schellekens A, de Jonge J, Bary F, Vollebergh W & Hendriks V. (2021). Youth in transition. A prospective cohort study into the long-term course of addiction, mental health problems and social functioning in youth entering addiction treatment: study protocol. BMC Psychiatry, 21: 605. doi: https://doi.org/10.1186/s12888-021-03520-8
  • Özgen H, Spijkerman R, Noack M, Holtmann M, Schellekens A, Dalsgaard S, ... & Hendriks V. (2021). Treatment of adolescents with concurrent substance use disorder and attention-deficit/hyperactivity disorder: A systematic review. Journal of clinical medicine, 10 (17), 3908.
  • Özgen H, Spijkerman R, Noack M, Holtmann M, Schellekens AS, van de Glind G, ... & Hendriks V. (2021). Internationale Konsenserklärung zu Screening, Diagnostik und Behandlung von Jugendlichen und Heranwachsenden mit Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung und gleichzeitigen Störungen durch Substanzgebrauch. Zeitschrift für Kinder-und Jugendpsychiatrie und Psychotherapie.
  • Özgen MH, Bolat GU, Spijkerman R, van den Brink W, Hendriks V, Ercan ES, & Emiroglu NI (2021). International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention Deficit Hyperactivity Disorder and Substance Use Disorder/Dikkat Eksikligi Hiperaktivite Bozuklugu ve Madde Kullanim Bozuklugu ES Tanisi Olan Ergenlerin Taranmasi, Tanisi ve Tedavisi icin Uluslararasi Fikir Birligi Beyani. Turkish Journal of Child and Adolescent Mental Health, 28 (2), 79-89.
  • Siriaraya P, Visch V, Boffo M, Spijkerman R, Wiers R, Korrelboom K, Hendriks V, Salemink E, van Dooren M, Bas M, Goossens R. (in press) JMIR Serious Games.
  • Spijkerman R, Crunelle C, Özgen H, Begeman A, Dom G, van de Glind G, … & Hendriks V. (2021). Screening, diagnostiek en behandeling van jongeren met een stoornis in het gebruik van middelen en ADHD: Internationale consensus. Geaccepteerd voor publicatie in: Tijdschrift voor Psychiatrie. 
  • Yuferov V, Butelman ER, Randesi M, van den Brink W, Blanken P, van Ree JM & Kreek MJ (2021). Association of serotonin transporter (SERT) polymorphisms with opioid dependence and dimensional aspects of cocaine use in a Caucasian cohort of opioid users. Neuropsychiatric Disease and Treatment, 17: 659-670. doi: 10.2147/NDT.S286536
     

2020

  • Van Benthem P, Spijkerman R, Blanken P, Kleinjan M, Vermeiren R, Hendriks V (2020). A dual perspective on first-session therapeutic alliance: strong predictor of youth mental health and addiction treatment outcome. European Child & Adolescent Psychiatry. doi: 10.1007/s00787-020-01503-w
  • Bhaskar S, Bradley S, Israeli-Korn S, Menon B, Chattu VK, Thomas P, Chawla J, Kumar R, Prandi P, Ray D, Golla S, Surya N, Yang H, Martinez S, Ozgen MH, Codrington J, González E, Toosi M, Hariya Mohan N, Menon KV, Mederer Hengstl, S (2020). Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium. Frontiers in neurology, 11, 664. doi: https://doi.org/10.3389/fneur.2020.00664
  • Blanken P, Nuijten M, van den Brink W & Hendriks V (2020). Clinical effects beyond cocaine use of sustained-release dexamphetamine for the treatment of cocaine dependent patients with comorbid opioid dependence: Secondary analysis of a double-blind, placebo-controlled randomised trial. Addiction, 115 (5): 917-923. doi: 10.1111/add.14874
  • van Dooren MM, Visch V, Spijkerman R, Goossens RH, & Hendriks VM (2020). Mental Health Therapy Protocols and eHealth Design: Focus Group Study. JMIR Formative Research, 4(5), e15568. doi: 10.2196/15568
  • Özgen H, Spijkerman R, Noack M, Holtmann M, Schellekens AS, van de Glind G, ... den Brink W & Hendriks V (2020). International consensus statement for the screening, diagnosis, and treatment of adolescents with concurrent attention-deficit/hyperactivity disorder and substance use disorder. European addiction research, 26(4-5), 223-232. doi: 10.1159/000508385 
  • Randesi M, Levran O, van den Brink W, Blanken P, van Ree JM, Ott J & Kreek MJ (2020). Further evidence for association of GAL, GALR1 and NPYR1 variants with opioid dependence. Pharmacogenomics, 21 (13): 903-917. [DOI: 10.2217/pgs-2020-0045]. . doi: https://doi.org/10.2217/pgs-2020-0045
     

2019

  • Blanken P, de Haan H & Dumont G (2019). De rol van psychostimulantia in de behandeling van patiënten met een stoornis in het gebruik van stimulantia (cocaïne en amfetamine) en comorbide ADHD. Psyfar.
  • Boumparis N,  Niesman LL, Blankers M, Ebert DD, Korf D, Schaub MP,  Spijkerman R, Tait RJ,   Riper H (2019). The short- and long-term effects of Internet-based prevention and treatment interventions for cannabis use reduction: A systematic review and meta-analysis. Drug and Alcohol Dependence.  doi: 10.1016/j.drugalcdep.2019.03.016
  • Van Dooren MM, Visch VT & Spijkerman R (2019). The design and application of game rewards in youth addiction care. Information, 10(4), 126. doi: 10.3390/info10040126
  • Van Dooren, M Siriaraya, P, Visch, V, Spijkerman, R, Bijkerk, L (2019). Reflections on the design, implementation, and adoption of a gamified eHealth application in youth mental healthcare. Entertainment Computing, 31, 100305. doi: 10.1016/j.entcom.2019.100305
  • Ozgen MH and S. Blume (2019). The continuing search for an addiction vaccine: persistence and ambiguity. Vaccine, Aug 23;37(36):5485-5490. doi: https://doi.org/10.1016/j.vaccine.2019.06.074
  • Randesi M, van den Brink W, Levran O, Blanken P, van Ree JM, Ott J & Kreek MJ (2019). VMAT2 gene (SLC18A2) variants associated with a greater risk for developing opioid dependence. Pharmacogenomics, 20 (5): 331-341. doi: 10.2217/pgs-2018-0137
  • Schee van der E, Hoekstra D & Los L (2019). Gameproblematiek bij jongeren: casuïstiek uit de behandelpraktijk. 
  • Yuferov V, Randesi M, Butelman ER, van den Brink W, Blanken P, van Ree JM, Ott J & Kreek MJ (2019). Association of variants of prodynorphin promoter 68 bp repeats in Caucasians with opioid dependence diagnosis: Effect on age trajectory of heroin use. Neuroscience Letters, 704: 100-105. doi: 10.1016/j.neulet.2019.03.038
  • Waters AJ, Schoenmakers TM, Snelleman M, Szeto E, Franken IHA, Hendriks VM, Van de Mheen D (2019).  Affect, motivation, temptation, and drinking among alcohol-dependent outpatients trying to maintain abstinence:  An Ecological Momentary Assessment study: An Ecological Momentary Assessment study. Drug and Alcohol Dependence doi: https://doi.org/10.1016/j.drugalcdep.2019.107626

2018

  • Blanken TF, Deserno MK, Dalege J, Borsboom D, Blanken P, Kerkhof GA & Cramer AOJ (2018). The role of stabilizing and communicating symptoms given overlapping communities in psychopathology networks. Scientific Reports, 8: 5854.
  • Herbrink M, Martínez-Moreno J, Nuijen B, Huitema ADR, Beijnen JH, Hendriks VM, Blanken P, Janmohamed A, Nuijten M & van den Brink W (2018). Pharmacokinetics of sustained-release oral dexamphetamine sulphate in crack-cocaine and heroin dependent patients. Journal of Clinical Psychopharmacology, 38: 212-217.
  • Noordraven EL, Wierdsma AI, Blanken P, Bloemendaal AFT & Mulder CL (2018). The effect of financial incentives on patients' motivation for treatment: Results of "Money for Medication," a randomised controlled trial. BMC Psychiatry, 18: 144.
  • Noordraven EL, Wierdsma AI, Blanken P, Bloemendaal AFT & Mulder CL (2018) Medical and social costs after using financial incentives to improve medication adherence: Results of a one year randomised controlled trial. BMC Research Notes, 11: 655.
  • Randesi M, van den Brink W, Levran O, Yuferov V, Blanken P, van Ree JM, Ott J & Kreek MJ (2018). Dopamine gene variants in opioid addiction: Comparison of dependent patients, nondependent users and healthy controls. Pharmacogenomics, 19 (2): 95-104.
  • Siriaraya P, Visch V, van Dooren MM & Spijkerman R (2018). Learnings and Challenges in Designing Gamifications for Mental Healthcare: The Case Study of the Readysetgoals Application. Paper presented at the 2018 10th International Conference on Virtual Worlds and Games for Serious Applications (VS-Games).
  • van Dooren MM, Visch VT & Spijkerman R (2018). Rewards that make you play: The Distinct effect of monetary rewards, virtual points and social rewards on play persistence in substance dependent and non-dependent adolescents. Paper presented at the 2018 IEEE 6th International Conference on Serious Games and Applications for Health (SeGAH).

2017

  • Geschiere ME, Spijkerman R & de Glopper A (2017). Risk of psychosocial problems in children whose parents receive substance abuse treatment. International Journal of Child, Youth and Family Studies, 8 (2): 11-36.
  • Noordraven E, Schermer MHN, Blanken P, Mulder CL, Wierdsma AI (2017). Ethical acceptability of offering financial incentives for taking antipsychotic depot medication: Patients' and clinicians' perspectives after a 12-month randomized controlled trial. BMC Psychiatry, 17: 313.
  • Noordraven EL, Wierdsma AI, Blanken P, Bloemendaal AFT, Staring ABP, Mulder CL (2017). Financial incentives for improving adherence to maintenance treatment in patients with psychotic disorders (Money for Medication): A multicentre, open-label, randomised controlled trial. The Lancet Psychiatry, 4 (3): 199-207.
  • Van der Pol TM, Henderson CE, Hendriks VM, Schaub MP, Rigter H (2017). Multidimensional family therapy reduces self-reported criminality among adolescents with a cannabis use disorder. International Journal of Offender Therapy and Comparative Criminology, 62: 1573-1588.
  • Schawo S, Bouwmans C, Van der Schee E, Hendriks VM, Brouwer W, Hakkaart L (2017). The search for relevant outcome measures for cost-utility analysis of systemic family interventions in adolescents with subtance use disorder and delinquent behavior: A systematic literature review. Health and Quality of Life Outcomes, 15: 179.
  • Teunissen HA, Spijkerman R, Kuntsche  E, Engels RC, & Scholte  R H (2017). Cool or fool? The association between drinker prototypes and alcohol consumption using multiple time-point diary assessments in adolescent males. Substance use & misuse, 52 (5): 656-665.

2016

  • Blanken P, Hendriks VM, Huijsman IA, van Ree JM, van den Brink W (2016). Efficacy of cocaine contingency management in heroin-assisted treatment: Results of a randomized controlled trial. Drug and Alcohol Dependence, 164: 55-63.
  • Bonebakker AE, van Nieuwkerk S, Vuijk R, Blanken P (2016). Een autismespectrum stoornis bij dubbel-diagnose patiënten: een verkennend onderzoek door middel van screening. Wetenschappelijk Tijdschrift Autisme, 15 (3): 119-125.
  • Van Dooren MM, Visch VT, Spijkerman R, Goossens RH, Hendriks VM (2016). Personalization in Game Design for Healthcare: a Literature Review on its Defintions and Effects. International Journal of Serious Games, 3 (4).
  • Goorden M, Van der Schee E, Hendriks VM, Hakkaart van Roijen L (2016). Cost-effectiveness of multidimensional family therapy compared to cognitive behavioral therapy for adolescents with a cannabis usedisorder: Data from a randomized controlled trial. Drug and Alcohol Dependence, 162, 154-161.
  • Goorden M, Schawo SJ, Bouwman-Frijters CAM, Van der Schee E, Hendriks VM, Hakkaart van Roijen L (2016). The cost-effectiveness of family-based therapy for treatment of externalising disorders, substance use disorders and delinquency: a systematic review. BMC Psychiatry: 16, 237.
  • Noordraven EL, Wierdsma AI, Blanken P, Bloemendaal AFT, Mulder CL (2016). Depot-medication compliance for patients with psychotic disorders: The importance of illness insight and treatment motivation. Neuropsychiatric Disease and Treatment, 12: 269-274.
  • Nuijten M, Blanken P, Van de Wetering B, Nuijen B, Van den Brink W & Hendriks V (2016). Dexamfetamine met vertraagde afgifte als behandeling van crackafhankelijkheid bij opiaatverslaafden die heroïne op medisch voorschrift ontvangen. Verslaving, 12, 207-216.
  • Nuijten M (2016). Substitutie met dexamfetamine SR naast medische heroïne bij chronische crack- en opiaatafhankelijkheid. Tijdschrift voor Psychiatrie, 58, 608-608.
  • Nuijten M, Blanken P, Van de Wetering B, Nuijen B, Van den Brink W, & Hendriks V (2016). Sustained- release dexamphetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled, double-blind trial. The Lancet, 387, 2226-2234.
  • Nuijten, M., Blanken, P., Van den Brink, W., Goudriaan, A., & Hendriks, V. (2016). Impulsivity and attentional bias as predictors of the treatment with modafinil on retention and drug use in crack-cocaine dependent patients: results of a randomised controlled trial. Journal of Psychopharmacology, 30, 616-626.
  • Randesi M, van den Brink W, Levran O, Blanken P, Butelman ER, Yuferov V, Correa da Rosa J, Ott J, van Ree JM, Kreek MJ (2016). Variants of opioid system genes are associated with non-dependent opioid use and heroin dependence. Drug and Alcohol Dependence, 168: 164-169.
  • Teunissen HA, Kuntsche E, Scholte RH, Spijkerman R, Prinstein MJ & Engels RC (2016). Friends' drinking norms and male adolescents' alcohol consumption: The moderating role of performance-based peer influence susceptibility. Journal of adolescence, 53: 45-54.

2015

  • Cousijn J, van Benthem P, van der Schee E, & Spijkerman R (2015). Motivational and control mechanisms underlying adolescent cannabis use disorders: A prospective study. Developmental cognitive neuroscience, 16, 36-45.
  • van Dooren MMM, Visch VT,  Goossens RHM,  Spijkerman R, Hendriks VM (2015). Personalized persuasive game design for youth addiction care. CHIPLAY 2015: Personalization in Serious and Persuasive Games and Gamified Interactions Workshop, London, UK, October 4, 2015.
  • Fischer B, Blanken P, Da Silveira D, Galassi A, Goldner EM, Rhem J, Tyndall M, Wood E (2015). Effectiveness of secondary prevention and treatment interventions for crack-cocaine abuse: A comprehensive narrative overview of English-language studies. International Journal of Drug Policy, 26: 352-363.
  • van der Kooij K, Hoogendoorn E, Spijkerman R & Visch V (2015). Validation of Serious Games. International Journal of Serious Games, 2(3).
  • Nuijten M, Blanken P, Van den Brink W, Hendriks VM (2015). Modafinil in the treatment of crack-cocaine dependence in the Netherlands: Results of a open label  randomised controlled feasibility trial. Journal of Psychopharmacology, 29, 678-687.
  • Oteo Pérez A, Benschop A, Blanken P, Korf DJ (2015) Criminal involvement and crime specialization among crack users in the Netherlands. European Addiction Research, 21 (2): 53-62.

Alle publicaties vanaf 2014 en ouder vind je hier